| (210) | Number of the EPO application | 17728614 |
| (220) | Filing date of the EPO application | 2017.06.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 28/2022, 2022.07.13 |
| (110) | EPO patent number | 3464265 |
| (11) | Number of the document | MD 3464265 T2 |
| (21) | Number of the application | e 2019 0411 |
| (71) | Name(s) of applicant(s), code of the country | Kalvista Pharmaceuticals Limited, GB; |
| (72) | Name(s) of inventor(s), code of the country | BEATON Haydn, GB;
CROWE David Malcolm, GB;
EDWARDS Hannah Joy, GB;
GRIFFITHS-HAYNES Nicholas James, GB; |
| (73) | Name(s) of owner(s), code of the country | KALVISTA PHARMACEUTICALS LIMITED, GB; |
| (54) | Title of the invention | Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 401/10 (2006.01.01); A61K 31/4439 (2006.01.01); A61P 29/00 (2006.01.01) |
| (19) | Country | GB |
| (41) | Date of publication of the application | 2019.05.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.12.31 |
| (30) | Priority | 201609607, 2016.06.01, GB; 201662344059 P, 2016.06.01, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/GB2017/051579, 2017.06.01 |
| (87) | International publication | WO 2017/208005, 2017.12.07 |